Rheumatological prescribing in athletes: A review of the new World Anti-Doping Agency guidelines

7Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Rheumatologists, with their musculoskeletal background, often care for athletes. The effect of a positive anti-doping test, whether through illegitimate use or accidental prescribing of banned drugs, is devastating to an athlete's career. It is therefore incumbent upon rheumatologists to be aware of issues relating to drugs in sport. This involves both therapeutic drugs and doping. It is vital to ensure that any substance prescribed should be approved for use and should not adversely affect (or benefit) the athlete's performance. In March 2004, 5 months prior to the 2004 Olympic Games in Athens, the joint World Anti-Doping Agency/International Olympic Committee published the revised list of banned substances in athletes. This article aims to provide an overview of the current status of medications commonly prescribed in rheumatological practice. © British Society for Rheumatology 2004; all rights reserved.

Cite

CITATION STYLE

APA

Smith, R., Barnsley, L., Kannangara, S., & Mace, A. (2004, December). Rheumatological prescribing in athletes: A review of the new World Anti-Doping Agency guidelines. Rheumatology. https://doi.org/10.1093/rheumatology/keh338

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free